Market Cap 966.67M
Revenue (ttm) 682.16M
Net Income (ttm) -187.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 7.97
Profit Margin -27.49%
Debt to Equity Ratio 0.00
Volume 14,726,400
Avg Vol 4,993,238
Day's Range N/A - N/A
Shares Out 160.84M
Stochastic %K 63%
Beta 3.15
Analysts Sell
Price Target $16.14

Latest News on NVAX

Vaccine stocks fall following FDA resignation

Mar 31, 2025, 6:21 PM EDT - 23 days ago

Vaccine stocks fall following FDA resignation

BNTX MRNA PFE PCVX PTCT XBI


Novavax Announces Changes to Board of Directors

Mar 11, 2025, 8:00 AM EDT - 6 weeks ago

Novavax Announces Changes to Board of Directors


Novavax to Participate in Upcoming March Investor Conferences

Feb 27, 2025, 4:05 PM EST - 7 weeks ago

Novavax to Participate in Upcoming March Investor Conferences


Novavax, Inc. (NVAX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:42 AM EST - 7 weeks ago

Novavax, Inc. (NVAX) Q4 2024 Earnings Call Transcript


Novavax Stock Is Rising. Revenue Beat Estimates.

Feb 27, 2025, 8:05 AM EST - 7 weeks ago

Novavax Stock Is Rising. Revenue Beat Estimates.


Novavax to Participate in Jefferies London Healthcare Conference

Nov 13, 2024, 8:00 AM EST - 5 months ago

Novavax to Participate in Jefferies London Healthcare Conference


Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway

Nov 13, 2024, 7:30 AM EST - 5 months ago

Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway


Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:52 AM EST - 5 months ago

Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript


Novavax Stock Dives Even Though Results Beat Forecasts

Nov 12, 2024, 9:44 AM EST - 5 months ago

Novavax Stock Dives Even Though Results Beat Forecasts


US FDA lifts clinical hold on Novavax's combo COVID-flu shot

Nov 11, 2024, 8:41 AM EST - 5 months ago

US FDA lifts clinical hold on Novavax's combo COVID-flu shot